InfYnity Biomarkers

InfYnity Biomarkers was founded in 2009 in Lyon (France). We are an R&D In-Vitro Diagnostics Company fully dedicated to infectious diseases and immunity. Company Mission: Maximizing Immunoassay Performance i.e. we have the ambition to set new criteria for immunoassays: study the diversity of immune response to provide high-value information instead of the binary response.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

RESEARCH

PRISM BIOLAB, ENTERS MULTI-PROJECT DRUG DISCOVERY COLLABORATION WITH ROCHE AND GENENTECH

PRISM BioLab Co., Ltd. | January 05, 2022

news image

PRISM BioLab, a Japan based biotechnology company with a proprietary peptide mimetic small molecule drug discovery platform, announced it has entered into a multi-target research collaboration and licensing agreement with Roche and Genentech, a member of the Roche Group. Under the terms of the agreement, PRISM BioLab will provide its proprietary library of peptide mimetic small molecules, the PepMetics Library, for screening against targets selected by Roche and Genentech. Upon id...

Read More

INDUSTRIAL IMPACT

FEN INDUSTRIES EARNS USDA CERTIFIED BIOBASED PRODUCT LABEL FOR TERREPLENISH® SOIL MICROBES

FEN Industries | February 22, 2022

news image

FEN announced today that it has earned the U.S. Department of Agriculture (USDA) Certified Biobased Product label. The product, Terreplenish®, has 97% biobased content. Third-party verification for a product's biobased content is administered through the USDA BioPreferred Program, an initiative created by the Farm Bill. The primary goal of the BioPreferred Program is to increase the development, purchase, and use of biobased products. Biobased products have ...

Read More

MEDICAL

HEALTHPARTNERS, HELIX PARTNER TO CREATE DNA TESTING PROGRAM THAT HELPS FAMILIES BETTER UNDERSTAND THEIR GENETIC HEALTH

Helix | March 09, 2022

news image

HealthPartners and leading genomics company, Helix, are launching myGenetics, a population genomics program that will provide important health information to families across Minnesota and surrounding states. The myGenetics program hopes to enroll more than 100,000 participants over four years. Genomic data generated will be integrated with patient health records and shared during their personal clinical care. Through the partnership, HealthPartners will be able to identify risk ea...

Read More

INDUSTRIAL IMPACT

TRANSPERFECT LIFE SCIENCES AND INNOVADERM RESEARCH EXPAND TRIAL INTERACTIVE PARTNERSHIP

TransPerfect Life Sciences | February 16, 2022

news image

TransPerfect Life Sciences, a leading provider of services and technologies to support global clinical trials and product development for the biopharmaceutical industry, today announced that Innovaderm will scale their implementation of Trial Interactive to further enable and optimize remote clinical operations. Innovaderm, a North America-based contract research organization (CRO) that specializes in clinical studies for dermatology, leveraged Trial Interactive remote monitoring ...

Read More
news image

RESEARCH

PRISM BIOLAB, ENTERS MULTI-PROJECT DRUG DISCOVERY COLLABORATION WITH ROCHE AND GENENTECH

PRISM BioLab Co., Ltd. | January 05, 2022

PRISM BioLab, a Japan based biotechnology company with a proprietary peptide mimetic small molecule drug discovery platform, announced it has entered into a multi-target research collaboration and licensing agreement with Roche and Genentech, a member of the Roche Group. Under the terms of the agreement, PRISM BioLab will provide its proprietary library of peptide mimetic small molecules, the PepMetics Library, for screening against targets selected by Roche and Genentech. Upon id...

Read More
news image

INDUSTRIAL IMPACT

FEN INDUSTRIES EARNS USDA CERTIFIED BIOBASED PRODUCT LABEL FOR TERREPLENISH® SOIL MICROBES

FEN Industries | February 22, 2022

FEN announced today that it has earned the U.S. Department of Agriculture (USDA) Certified Biobased Product label. The product, Terreplenish®, has 97% biobased content. Third-party verification for a product's biobased content is administered through the USDA BioPreferred Program, an initiative created by the Farm Bill. The primary goal of the BioPreferred Program is to increase the development, purchase, and use of biobased products. Biobased products have ...

Read More
news image

MEDICAL

HEALTHPARTNERS, HELIX PARTNER TO CREATE DNA TESTING PROGRAM THAT HELPS FAMILIES BETTER UNDERSTAND THEIR GENETIC HEALTH

Helix | March 09, 2022

HealthPartners and leading genomics company, Helix, are launching myGenetics, a population genomics program that will provide important health information to families across Minnesota and surrounding states. The myGenetics program hopes to enroll more than 100,000 participants over four years. Genomic data generated will be integrated with patient health records and shared during their personal clinical care. Through the partnership, HealthPartners will be able to identify risk ea...

Read More
news image

INDUSTRIAL IMPACT

TRANSPERFECT LIFE SCIENCES AND INNOVADERM RESEARCH EXPAND TRIAL INTERACTIVE PARTNERSHIP

TransPerfect Life Sciences | February 16, 2022

TransPerfect Life Sciences, a leading provider of services and technologies to support global clinical trials and product development for the biopharmaceutical industry, today announced that Innovaderm will scale their implementation of Trial Interactive to further enable and optimize remote clinical operations. Innovaderm, a North America-based contract research organization (CRO) that specializes in clinical studies for dermatology, leveraged Trial Interactive remote monitoring ...

Read More